IFS Advisors’s AbbVie ABBV Stock Holding History

IFS Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$52.3K	Hold	200	–	–	0.02%	188
2026 Q2	$50.3K	Hold	200	–	–	0.02%	59
2026 Q1	$43.5K	Hold	200	–	–	0.02%	60
2025 Q4	$45.7K	Hold	200	–	–	0.02%	50
2025 Q3	$46.3K	Hold	200	–	–	0.03%	49
2025 Q2	$37.1K	Sell	200 -300	-60%	-$55.8K	0.03%	44
2025 Q1	$105K	Hold	500	–	–	0.09%	24
2024 Q4	$88.8K	Buy	500 +300	+150%	+$55.2K	0.07%	25
2024 Q3	$39.5K	Hold	200	–	–	0.03%	34
2024 Q2	$34.3K	Hold	200	–	–	0.03%	33
2024 Q1	$36.4K	Buy	+200	New	+$34.5K	0.03%	34

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return

Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return

Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

IFS Advisors's ABBV Position: Q3 2026 in Review

IFS Advisors held its AbbVie (ABBV) position steady in Q3 2026 at 200 shares worth $52.3K. The position accounts for 0.02% of the portfolio, ranked #188.

IFS Advisors first reported a position in ABBV in Q1 2024 and has held it in 11 quarters since. The position peaked at $105K in Q1 2025. 1,311 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

IFS Advisors held 200 shares of AbbVie worth $52.3K as of Q3 2026.
IFS Advisors left its AbbVie share count unchanged in Q3 2026.
AbbVie made up 0.02% of IFS Advisors's portfolio in Q3 2026, its #188 holding.
IFS Advisors first reported a position in AbbVie in Q1 2024 and has held it in 11 quarters since.
IFS Advisors's AbbVie position peaked at $105K in Q1 2025.
1,311 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on IFS Advisors's 13F filing for Q3 2026, filed 14 Oct 2026.